Trademark: AMONDYS 45 (CASIMERSEN)
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
AMONDYS 45 (CASIMERSEN)
Click here to search for trademarks similar to AMONDYS 45 (CASIMERSEN)
Proof of use for AMONDYS 45 (CASIMERSEN)
We do not have any records of a proof of use for AMONDYS 45 (CASIMERSEN) at this moment.
Click here to add a proof of use for AMONDYS 45 (CASIMERSEN)
Possible trademark infringements of AMONDYS 45 (CASIMERSEN)
Basic Information about AMONDYS 45 (CASIMERSEN)
- Serial Number
- 90458567
- Filing Date
- 11 Jan 2021
- Registration Number
- 6564415
- Registration Date
- 16 Nov 2021
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of AMONDYS 45 (CASIMERSEN) on the blockchain with WikiTrademarks.io.
- First use of AMONDYS 45 (CASIMERSEN) anywhere
- AMONDYS 45 (CASIMERSEN) was first used on 25 Feb 2021 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns AMONDYS 45 (CASIMERSEN)?
1. Sarepta Therapeutics, Inc. Cambridge MA
2. Sarepta Therapeutics, Inc. Cambridge MA
3. Sarepta Therapeutics, Inc. Cambridge MA
Correspondent
- Maury M. Tepper, III
- TEPPER & EYSTER, PLLC
- 3724 BENSON DRIVE
- RALEIGH, NC 27609
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io